Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Northwest Bio gains key regulatory approval in Germany
Monday, March 10, 8:25 AM ET | NWBO
Northwest Biotherapeutics (NWBO) gets a "Hospital Exemption" early access program for DCVax-L from German regulators. This means that the company may provide the product to patients for the treatment of Glioblastoma multforme and lower grades of gliomas outside of its clinical trial and charge full price.
The approval term is five years.
The German reimbursement authority approves DCVax-L eligibility for reimbursement from the Sickness Funds (health insurers). The specific level of payment will be negotiated by the company, hospitals and insurers.
Likely, the answer is right in front of you....price target for purchase is not here.
Likely the 5000 puts they had in a security/derivative mutually beneficial deal they made with institution "X" in the interim. Just a guess, but it is their MO.
No argument here.
You need to be aware that a piece, whether bullish or bearish in nature, can be from any number of financiers with substantial interest in this company. My first instinct would be to luck at institutional holdings, then cross reference with associated HF involvement, and that would be a more likely culprit with a much less public eye footprint. They are sneaky bastards...and often in bed with institutional investors via security/derivative exchange agreements which circumvent litigational regulation by governing bodies such as the SEC and FINRA regarding manipulation.
That's about it. I usually by some cheaper further out of the money strikes on some plays that I think may be explosive, but sometimes they end up in no mans land. CHTP was a recent example. It's ok to have them, but getting more with closer strikes will guarantee profit on the trade. If it does explode, then it's miller time
The Jan 2015 call could be good after approval, but I wouldn't use that for a "Strangle"....I added May $7 calls a few weeks ago at a good price, still haven't locked in the put side yet, but I figure I can the, on the cheap over the next couple weeks.
If you go for cheap shares by trying to get the Strangle locked in here and now, you will likely not get the best prices, so you would need to go further out of the money. I could see a muted response to positive news, remaining range bound in a 30-40% range, at which point the MMs will drop IV on all options. Don't forget, these big institutional holders of stock shares are also the largest sellers of options. They plan to keep those short of their respective strikes for the front month of announcement.
I think you should be patient and try to add at cheaper premiums over the coming days/weeks in order to get a little tighter strike range. As for the 2015 calls, I like that as a side bet. I'm currently in ARIA, ABX, and CHTP with 2015 calls. I don't do that a lot, but I like it for when I see a steady rise in prices over a year. GL
Dendreon Will Get Much Worse Before It Gets Better
http://seekingalpha.com/article/2065863-dendreon-will-get-much-worse-before-it-gets-better
Not any time soon. This is a funding measure pre-ADCOM to have something in place without immediate dilution. If approved, I'd watch the $7.50+ levels.
This shouldn't affect the run-up, and I'm guessing the ADCOM price action either. If approved at PDUFA, that's when I would be nimble with the sell button. Good luck all
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
$50,000,000
MannKind Corp.
Common Stock
We have entered into two at-the-market issuance sales agreements, one with MLV & Co. LLC, or MLV, and one with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.), or Brinson Patrick, relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying prospectus. We may offer and sell shares of our common stock, $0.01 par value per share, having an aggregate offering price of up to $50,000,000 from time to time through MLV or Brinson Patrick, whom we collectively refer to herein as the Agents, as our sales agents provided that in no event will we sell more than 25,000,000 shares in this offering.
Our common stock is listed on The NASDAQ Global Market under the symbol “MNKD.” The last reported sale price of our common stock on February 27, 2014 was $6.39 per share.
Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus will be made by any method that is deemed an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act, including by means of ordinary brokers’ transactions at market prices, in negotiated transactions or as otherwise agreed by the applicable Agent and us. Neither Agent is required to sell a certain number of shares or dollar amount of our common stock. Rather, each Agent will act as our sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
Each Agent will be entitled to a commission of up to 3% of the gross sales price per share sold under the sales agreement with that Agent. In connection with the sale of the common stock on our behalf, the applicable Agent may be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the Agent may be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to each Agent with respect to certain liabilities, including liabilities under the Securities Act.
Investing in our securities involves significant risks. Before buying shares of our common stock, you should carefully consider the risk factors described in “ Risk Factors ” beginning on page S-3 of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and any free writing prospectus that we have authorized for use in connection with this offering.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus is accurate or complete. Any representation to the contrary is a criminal offense.
"Risks Related to this Offering
Management will have broad discretion as to the use of the proceeds from this offering, and may not use the proceeds effectively.
Because we have not designated the amount of net proceeds from this offering to be used for any particular purpose, our management will have broad discretion as to the application of the net proceeds from this offering and could use them for purposes other than those contemplated at the time of the offering. Our management may use the net proceeds for corporate purposes that may not improve our financial condition or market value.
You may experience immediate and substantial dilution in the book value per share of the common stock you purchase in the offering.
The offering price per share in this offering may exceed the net tangible book value per share of our common stock outstanding prior to this offering. Assuming that an aggregate of 7,824,726 shares of our common stock are sold at a price of $6.39 per share, the last reported sale price of our common stock on The NASDAQ Global Market on February 27, 2014 for aggregate gross proceeds of approximately $50.0 million, and after deducting commissions and estimated aggregate offering expenses payable by us, you will experience immediate dilution of $6.34 per share, representing the difference between our as adjusted net tangible book value per share as of December 31, 2013 after giving effect to this offering at the assumed size and offering price. The exercise of outstanding stock options and warrants will result in further dilution of your investment. See “Dilution” for a more detailed illustration of the dilution you would incur if you participate in this offering.
You may experience future dilution as a result of future equity offerings.
In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the price per share paid by investors in this offering."
Not an offering, it's an ATM. Nor have they exercised any of the $50Mil in shares as of yet. Read at the bottom of Page 52 on he amendment filed last night. On the surface, it seems to be an attempt to avoid a secondary in order to accomplish the same effect for funding, yet at market upon execution and subsequent selling on the secondary market. Not sure how I feel about this....a lot of shares here. Generally this won't be a problem until there is a run, which will likely be muted by the ax (ATM) at certain levels. Hope for a massive run with tremendous volume on good news. May want to consider selling further out of the money calls.
No. I'm not implying she is lying. But if you were the one with the money invested, wouldn't you be inclined to paint the best picture possible? I know your answer already so don't bother. But just think for a minute about it. Either way, I hope the beat for all longs. I personally am an options trader and have already taken all cost basis off the table for this trade ( strangle at $5.00). I bought back the 1:1 trade today at the low. Good luck to you and all here. I hope for a great outcome, but remain a realist and a person who is good at making money in bio.
Which is exactly why that's not a good argument.
Agreed, took small position today.
Sorry, meant to copy and paste this:
Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)
Table of Contents
As filed with the Securities and Exchange Commission on March 3, 2014
Registration No. 333-190040
This registration statement relates to the resale by the selling stockholders named herein of the shares of common stock, par value $0.01 per share, of the registrant issuable upon conversion of convertible notes held by the selling stockholders named herein pursuant to a Facility Agreement dated July 1, 2013, as amended on February 28, 2014. The number of shares reflected in the table above includes 7,852,474 of the total 12,000,000 shares of common stock previously registered in connection with the filing of this registration statement on July 19, 2013, which have been sold under this registration statement by the selling stockholders named herein prior to the date hereof. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also registers an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
(2) Estimated solely for purposes of calculating the registration fee under Rule 457(c) under the Securities Act, based on the average of the high and low trading prices of our common stock reported on The NASDAQ Global Market on February 28, 2014.
(3)
I'm a big fan of triple confirmations.
RSI, MACD, CMF(or A/D)
Sounds like a plan. I'm largely a volatility trader, tend to short contracts often. Good luck with these. I think you should do well, unless it gets tweeted that Putin and Obama hug it out.
You have a largely bearish sentiment on this ledger....you should make some good money today. Nice trades.
I'd rather them take their time. Any positive news will be muted with the unrest in the Ukraine.
Agreed, GL to you as well.
You too
Everything is knee jerk right now. With the bloated P/Es, QE synthesized "strength" and minimal, truly fundamental catalysts, everything is knee jerk. Hard to find pure, fundamental momentum these days.
Major U.S. stock index futures are all off about 1% as the chance of military conflict in Eastern Europe builds following Russia's seizing of control of Ukraine's Crimean peninsula.
"[An] incredible act of aggression," says Secretary of State John Kerry as he heads to Kiev to show support for the new Ukrainian government.
Gold has its tail way in the air, up 1.6% to $1,344 per ounce, and money is also flowing into U.S. Treasurys with the 10-year yield off five basis points to 2.60%. WTI crude oil is ahead 1.5% to $104.16.
Major U.S. stock index futures are all off about 1% as the chance of military conflict in Eastern Europe builds following Russia's seizing of control of Ukraine's Crimean peninsula.
"[An] incredible act of aggression," says Secretary of State John Kerry as he heads to Kiev to show support for the new Ukrainian government.
Gold has its tail way in the air, up 1.6% to $1,344 per ounce, and money is also flowing into U.S. Treasurys with the 10-year yield off five basis points to 2.60%. WTI crude oil is ahead 1.5% to $104.16.
Should get more interesting Monday....
Ukraine Capital Control Crunch: Largest Bank Limits Cash Withdrawals To $100 Daily
As we warned on Friday, the military escalation in Ukraine has had dire consequences for the financial state of the country, its banks, and ultimately its people. The central bank promised to rescue domestic banks so long as they agreed to its complete control and it appears the first consequences of that "we are here to help you" promise is coming true:
UKRAINE'S PRIVATBANK LIMITS ATM WITHDRAWALS TO UAH1,000/DAY ($103/day)
Privatbank is Ukraine's largest bank and while claiming this move is temporary (just like Cyprus' capital controls), the bank has also ceased new loans amid what it calls "geopolitical instability". In summary, you can't have your money back! Expect long angry lines at Ukrainian banks on Monday morning (and at the pace of collapse in the Hyrvnia, hyperinflation next).
Via WSJ,
Ukraine's largest commercial bank, Privatbank, announced temporary limits on cash withdrawals for its account holders and suspended writing new loans, saying in a statement the measures were intended to stop those undermining the political situation in the country. "A temporary limit on withdrawals is needed to stop the forces that are working to destabilize the situation [and] are using the cash for [their] sabotage," the bank said in a statement. The bank didn't clarify which political forces it was referring to.
The bank first announced withdrawal limits of 1,000 hryvnia ($103) a day at both automated teller machines and in over-the-counter transactions.
...
Privatbank's announcement was the first case in which a major Ukrainian bank has limited customers' immediate access to cash in the local currency since the military tensions erupted. Privatbank is the largest retail bank by number of clients in Ukraine, a country of approximately 45 million people.
Last week, the National Bank of Ukraine introduced a $1,500 daily limit on foreign-currency withdrawal.
But perhaps the most notable, somewhat hidden, comment from the bank was this:
Privatbank said it was suspending all its credit lines issued to both private and corporate customers, including credit cards. It said it would no longer accept debit cards from other banks in the Crimea.
In other words, we won't allow the people of Crimea (the region now in play with the Russians) to 'run' on our bank...
Privatbank said its measures were a "rational" response to the current situation and they were designed to help the bank serve its customers and protect the national currency.
We wonder what 'loophole' the uber-wealthy will find (as in Cyprus deposit shifts to the UK) to extract their deposits before the real capital controls collapse the currency.
And is is how it starts....
Ukraine Capital Control Crunch: Largest Bank Limits Cash Withdrawals To $100 Daily
As we warned on Friday, the military escalation in Ukraine has had dire consequences for the financial state of the country, its banks, and ultimately its people. The central bank promised to rescue domestic banks so long as they agreed to its complete control and it appears the first consequences of that "we are here to help you" promise is coming true:
UKRAINE'S PRIVATBANK LIMITS ATM WITHDRAWALS TO UAH1,000/DAY ($103/day)
Privatbank is Ukraine's largest bank and while claiming this move is temporary (just like Cyprus' capital controls), the bank has also ceased new loans amid what it calls "geopolitical instability". In summary, you can't have your money back! Expect long angry lines at Ukrainian banks on Monday morning (and at the pace of collapse in the Hyrvnia, hyperinflation next).
Via WSJ,
Ukraine's largest commercial bank, Privatbank, announced temporary limits on cash withdrawals for its account holders and suspended writing new loans, saying in a statement the measures were intended to stop those undermining the political situation in the country. "A temporary limit on withdrawals is needed to stop the forces that are working to destabilize the situation [and] are using the cash for [their] sabotage," the bank said in a statement. The bank didn't clarify which political forces it was referring to.
The bank first announced withdrawal limits of 1,000 hryvnia ($103) a day at both automated teller machines and in over-the-counter transactions.
...
Privatbank's announcement was the first case in which a major Ukrainian bank has limited customers' immediate access to cash in the local currency since the military tensions erupted. Privatbank is the largest retail bank by number of clients in Ukraine, a country of approximately 45 million people.
Last week, the National Bank of Ukraine introduced a $1,500 daily limit on foreign-currency withdrawal.
But perhaps the most notable, somewhat hidden, comment from the bank was this:
Privatbank said it was suspending all its credit lines issued to both private and corporate customers, including credit cards. It said it would no longer accept debit cards from other banks in the Crimea.
In other words, we won't allow the people of Crimea (the region now in play with the Russians) to 'run' on our bank...
Privatbank said its measures were a "rational" response to the current situation and they were designed to help the bank serve its customers and protect the national currency.
We wonder what 'loophole' the uber-wealthy will find (as in Cyprus deposit shifts to the UK) to extract their deposits before the real capital controls collapse the currency.
I agree, but if a major paradigm shift in sovereign markets were to occur (big assumption) I could see metals regaining safe haven status, synthetically shifting sentiment and money flow among sectors, not to mention interest rate fluctuations and broad market corrections should America go to war. Just some coffee talk. Anyway, Happy Sunday
With there unrest n the Ukraine and massive presence of Russian real estate investors in the US, I wonder if there will be any implications on American realty sectors as an indirect result of a weakened Soviet economy. Long-term thinking assuming this escalates. Watch for patterns in the futures over the coming weeks.
With the massive presence of Russian real estate investors in the US, I wonder if there will be any implications on American realty sectors as an indirect result of a weakened Soviet economy. Long-term thinking assuming this escalates.
Still waiting on Alice here. But I remain hopeful for this little guy. Hope all is well my friend. We need to catch up soon. Summer may be a very profitable one here assuming we can get the ball rolling again. May take a small position for a scalp on the upcoming Markman next month....little hesitant.
Sold half call position for 80%....so far total on Strangle trade 115%
You are going to drive yourself crazy doing this. I've said this a million times on here....when these large orders go through at the tape, they are almost always, without exception, balancing of the books by MMs to meet regulatory standards. If you look through the tape from the day there will be a buy for that exact amount that was put through as a credit. This should be illegal, however it happens every day due to credit limits established with a ledger as synthetic collateral. This means nothing.
ITMN
InterMune's Pirfenidone meets Phase III trial goals
Tuesday, February 25, 7:34 AM ET | ITMN
InterMune's (ITMN) Pirfenidone drug met the primary goal of a Phase III trial by significantly reducing the progression of idiopathic pulmonary fibrosis (IPF) or mortality.
"IPF is an irreversible and ultimately fatal disease characterized by progressive loss of lung function due to fibrosis (scarring) in the lungs, which hinders the ability of lungs to absorb oxygen," InterMune explains. IPF's five-year survival rate is 20-40%.
Pirfenidone also met secondary endpoints with improvements in six-minute walk tests and progression-free survival.
InterMune now plans to resubmit an application for FDA authorization of Pirfenidone.
Trading in the firm's shares has been halted. (PR)
ITMN
InterMune's Pirfenidone meets Phase III trial goals
Tuesday, February 25, 7:34 AM ET | ITMN
InterMune's (ITMN) Pirfenidone drug met the primary goal of a Phase III trial by significantly reducing the progression of idiopathic pulmonary fibrosis (IPF) or mortality.
"IPF is an irreversible and ultimately fatal disease characterized by progressive loss of lung function due to fibrosis (scarring) in the lungs, which hinders the ability of lungs to absorb oxygen," InterMune explains. IPF's five-year survival rate is 20-40%.
Pirfenidone also met secondary endpoints with improvements in six-minute walk tests and progression-free survival.
InterMune now plans to resubmit an application for FDA authorization of Pirfenidone.
Trading in the firm's shares has been halted. (PR)
It's the Monday after option expiration on a company with looming catalyst. This runup tried to happen Friday, but MMs kept it down.
This is a typical settling of the books by MMs. It allows them to satisfy certain bellwethers for short and derivative regulations. This is common in most high beta stocks, but can be seen as institutional interest increases in a stock. It's always right at the bell. Not an individual investor likely.
I am aware of the Phase 2b data for Vintifolide....what. The second catalyst you are referring to?
It's almost a cut and paste job....he does it at least once a month. It makes me laugh every time